MacroGenics | Aktywa



Current Assets Zmiana Data
AbbVie USD 25.58B 2.2B 2024-12
Amgen USD 29.03B 2.26B 2024-12
AstraZeneca USD 25.83B 1.67B 2024-12
Biogen USD 7.46B 626.3M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Daiichi Sankyo JPY 1.91T 66.22B 2025-03
Eli Lilly USD 32.74B 1.32B 2024-12
Genmab DKK 27.85B 4.16B 2024-12
Geron USD 490.99M 92.94M 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
J&J USD 55.89B 2.64B 2024-12
MacroGenics USD 217.49M 4.71M 2024-12
Merck USD 38.78B 1.58B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Regeneron Pharmaceuticals USD 27.21B 7.88B 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Xencor USD 577.6M 4.27M 2024-12



MacroGenics Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.